Exponent, Inc. (NASDAQ:EXPO – Get Free Report) Director Paul R. Johnston sold 7,000 shares of the company’s stock in a transaction on Monday, June 17th. The shares were sold at an average price of $95.50, for a total transaction of $668,500.00. Following the sale, the director now owns 80,742 shares of the company’s stock, valued at approximately $7,710,861. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.
Exponent Stock Performance
Shares of Exponent stock opened at $96.48 on Wednesday. The firm has a fifty day moving average of $90.67 and a two-hundred day moving average of $85.82. The stock has a market capitalization of $4.89 billion, a price-to-earnings ratio of 48.73 and a beta of 0.65. Exponent, Inc. has a 52 week low of $64.61 and a 52 week high of $102.72.
Exponent (NASDAQ:EXPO – Get Free Report) last released its quarterly earnings data on Thursday, April 25th. The business services provider reported $0.59 EPS for the quarter, beating analysts’ consensus estimates of $0.46 by $0.13. Exponent had a net margin of 18.72% and a return on equity of 28.13%. The business had revenue of $137.21 million during the quarter, compared to analysts’ expectations of $125.98 million. During the same quarter in the prior year, the company earned $0.56 EPS. The firm’s quarterly revenue was up 6.6% on a year-over-year basis. As a group, research analysts forecast that Exponent, Inc. will post 1.92 EPS for the current fiscal year.
Exponent Announces Dividend
Wall Street Analyst Weigh In
Several analysts have commented on EXPO shares. StockNews.com upgraded shares of Exponent from a “sell” rating to a “hold” rating in a research report on Monday, March 4th. Truist Financial upped their target price on shares of Exponent from $95.00 to $100.00 and gave the company a “buy” rating in a research report on Monday, April 29th.
Read Our Latest Report on EXPO
Institutional Trading of Exponent
A number of large investors have recently made changes to their positions in EXPO. Operose Advisors LLC bought a new stake in shares of Exponent in the 3rd quarter valued at $39,000. Benjamin F. Edwards & Company Inc. boosted its stake in Exponent by 866.0% in the 1st quarter. Benjamin F. Edwards & Company Inc. now owns 512 shares of the business services provider’s stock worth $42,000 after purchasing an additional 459 shares during the period. Janiczek Wealth Management LLC boosted its stake in Exponent by 293.7% in the 1st quarter. Janiczek Wealth Management LLC now owns 626 shares of the business services provider’s stock worth $52,000 after purchasing an additional 467 shares during the period. Principal Securities Inc. acquired a new position in Exponent in the 4th quarter worth $69,000. Finally, YHB Investment Advisors Inc. acquired a new position in Exponent in the 1st quarter worth $75,000. Institutional investors own 92.37% of the company’s stock.
Exponent Company Profile
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Featured Stories
- Five stocks we like better than Exponent
- How to Invest in the Best Canadian StocksĀ
- Occidental Stock: Buffett’s 9-Day Buying Spree Lifts Stake to 29%
- Canada Bond Market Holiday: How to Invest and Trade
- 3M Stock: Invest Now for Unmatched Quality and Growth Potential
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Super Micro AI Stock: Should You Invest After a 275% Increase?
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.